medi-cal glp-1 coverage MCT2D Employers Take a Variety of
Description
Why the slow ramp
These drugs mimic the glucagon-like peptide-1 hormone, which helps regulate blood sugar and appetite
Dig Dis Sci 2003
Support for overall metabolic efficiency, contributing to a more active and healthier lifestyle
Conclusions Manufacturers of brand-name GLP-1 receptor agonists have obtained periods of market exclusivity on their products through extensive patents and regulatory exclusivities that are positioned to be longer than other classes of drug-device combinations and especially small-molecule oral medications
In addition, long-term cardiovascular outcome trials have provided important reassurance
